Denali Therapeutics Inc.

NMS: DNLI

Live Quote

📈 ZcoreAI Score

Our AI model analyzes Denali Therapeutics Inc.'s price action across multiple timeframes using regression channels and statistical scoring.

Get DNLI Z-Score →

About Denali Therapeutics Inc.

Healthcare Biotechnology

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.

📊 Fundamental Analysis

Denali Therapeutics Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.

Return on Equity (ROE) is -45.7%, which indicates that capital utilization is currently under pressure.

At a current price of $19.23, DNLI currently sits at the 60th percentile of its 52-week range (Range: $12.30 - $23.77).

🏥 Financial Health

🔴 Profit Margin Weak

🔴 Debt/Equity Elevated

🔴 Return on Equity Weak

⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap

$3.05B

Trailing P/E

Forward P/E

-7.59

Beta (5Y)

1.10

52W High

$23.77

52W Low

$12.30

Avg Volume

1.79M

Day High

Day Low

Get DNLI Z-Score on Dashboard 🚀